Kahun launches AI agent for knowledge sharing aimed at pharmaceuticals

What you need to know:

– Kahun, a pioneer in medical knowledge structuring, has introduced a new AI agent specifically designed for the pharmaceutical industry.

– The AI ​​Agent aims to bridge the gap between medical knowledge and the patient context and provide professionals with reliable and accessible information about medicines.

Addressing the Challenges of Pharmaceutical Information

The rapid pace of drug development and research has made it increasingly difficult for healthcare professionals to stay abreast of the latest developments. Kahun’s AI Agent addresses this challenge by structuring medical knowledge in a way that is easily accessible and understandable.

Benefits for pharmaceutical companies

Using Kahun’s AI Agent, pharmaceutical companies can:

• Improve patient management: Gain insight into patient needs and identify potential treatment options.
• Reduce the number of medication dispensing points: Empower professionals with the information they need to optimize patient outcomes.
• Promote product awareness: Increase awareness of existing and new pharmaceutical products.

“The launch of a pharma-focused AI Agent is another significant milestone for our team in improving patients’ lives by providing healthcare professionals with tools that make a positive difference in their workflows,” said Dr. Michal Tzuchman Katz, CEO and co-founder of Kahun. “New medical knowledge is becoming available at a rapid and exciting pace, but it adds a tremendous amount of information for healthcare professionals to navigate. With workloads already impacting the doctor-patient interaction, our tool is built to make knowledge easily accessible.”